236 related articles for article (PubMed ID: 30380823)
1.
Quan K; Zhu Z; Cao S; Zhang F; Miao C; Wen X; Huang X; Wen Y; Wu R; Yan Q; Huang Y; Ma X; Han X; Zhao Q
J Microbiol Biotechnol; 2018 Dec; 28(12):2095-2105. PubMed ID: 30380823
[TBL] [Abstract][Full Text] [Related]
2. Galactose-1-phosphate uridyltransferase (GalT), an in vivo-induced antigen of Actinobacillus pleuropneumoniae serovar 5b strain L20, provided immunoprotection against serovar 1 strain MS71.
Zhang F; Zhao Q; Quan K; Zhu Z; Yang Y; Wen X; Chang YF; Huang X; Wu R; Wen Y; Yan Q; Huang Y; Ma X; Han X; Cao S
PLoS One; 2018; 13(6):e0198207. PubMed ID: 29856812
[TBL] [Abstract][Full Text] [Related]
3. A trivalent Apx-fusion protein delivered by E. coli outer membrane vesicles induce protection against Actinobacillus pleuropneumoniae of serotype 1 and 7 challenge in a murine model.
Xu K; Zhao Q; Wen X; Wu R; Wen Y; Huang X; Huang Y; Yan Q; Han X; Ma X; Chang YF; Cao S
PLoS One; 2018; 13(1):e0191286. PubMed ID: 29373591
[TBL] [Abstract][Full Text] [Related]
4. Nasal immunization with major epitope-containing ApxIIA toxin fragment induces protective immunity against challenge infection with Actinobacillus pleuropneumoniae in a murine model.
Seo KW; Kim SH; Park J; Son Y; Yoo HS; Lee KY; Jang YS
Vet Immunol Immunopathol; 2013 Jan; 151(1-2):102-12. PubMed ID: 23200821
[TBL] [Abstract][Full Text] [Related]
5. Contribution of adjuvant to adaptive immune responses in mice against Actinobacillus pleuropneumoniae.
San Gil F; Turner B; Walker MJ; Djordjevic SP; Chin JC
Microbiology (Reading); 1999 Sep; 145 ( Pt 9)():2595-2603. PubMed ID: 10517613
[TBL] [Abstract][Full Text] [Related]
6. DNA vaccine encoding type IV pilin of Actinobacillus pleuropneumoniae induces strong immune response but confers limited protective efficacy against serotype 2 challenge.
Lu YC; Li MC; Chen YM; Chu CY; Lin SF; Yang WJ
Vaccine; 2011 Oct; 29(44):7740-6. PubMed ID: 21835218
[TBL] [Abstract][Full Text] [Related]
7. Induction of antigen-specific immune responses by oral vaccination with Saccharomyces cerevisiae expressing Actinobacillus pleuropneumoniae ApxIIA.
Shin SJ; Bae JL; Cho YW; Lee DY; Kim DH; Yang MS; Jang YS; Yoo HS
FEMS Immunol Med Microbiol; 2005 Feb; 43(2):155-64. PubMed ID: 15681145
[TBL] [Abstract][Full Text] [Related]
8. Be Aware of Immunogenic But not Protective Antigens: The Actinobacillus pleuropneumoniae PalA as an Example.
Liu C; Cao Y; Yang J; Zhao H; Zahid KR; Zhao J; Qi C; Liu J
Protein Pept Lett; 2017; 24(11):1059-1065. PubMed ID: 28828973
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide screening of lipoproteins in Actinobacillus pleuropneumoniae identifies three antigens that confer protection against virulent challenge.
Cao Y; Gao L; Zhang L; Zhou L; Yang J; Deng L; Zhao J; Qi C; Liu J
Sci Rep; 2020 Feb; 10(1):2343. PubMed ID: 32047221
[TBL] [Abstract][Full Text] [Related]
10. Positive role for rApxIVN in the immune protection of pigs against infection by Actinobacillus pleuropneumoniae.
Wang C; Wang Y; Shao M; Si W; Liu H; Chang Y; Peng W; Kong X; Liu S
Vaccine; 2009 Sep; 27(42):5816-21. PubMed ID: 19654060
[TBL] [Abstract][Full Text] [Related]
11. Interference of outer membrane protein PalA with protective immunity against Actinobacillus pleuropneumoniae infections in vaccinated pigs.
van den Bosch H; Frey J
Vaccine; 2003 Sep; 21(25-26):3601-7. PubMed ID: 12922088
[TBL] [Abstract][Full Text] [Related]
12. In vivo testing of novel vaccine prototypes against Actinobacillus pleuropneumoniae.
Antenucci F; Fougeroux C; Deeney A; Ørskov C; Rycroft A; Holst PJ; Bojesen AM
Vet Res; 2018 Jan; 49(1):4. PubMed ID: 29316978
[TBL] [Abstract][Full Text] [Related]
13. Generation, safety and immunogenicity of an Actinobacillus pleuropneumoniae quintuple deletion mutant SLW07 (ΔapxICΔapxIICΔorf1ΔcpxARΔarcA).
Yuan F; Liu J; You W; Bei W; Wang C; Zhao J; Tian Y; Liu S
Vaccine; 2018 Mar; 36(14):1830-1836. PubMed ID: 29486946
[TBL] [Abstract][Full Text] [Related]
14. Employing Escherichia coli-derived outer membrane vesicles as an antigen delivery platform elicits protective immunity against Acinetobacter baumannii infection.
Huang W; Wang S; Yao Y; Xia Y; Yang X; Li K; Sun P; Liu C; Sun W; Bai H; Chu X; Li Y; Ma Y
Sci Rep; 2016 Nov; 6():37242. PubMed ID: 27849050
[TBL] [Abstract][Full Text] [Related]
15. Identification of proteins of Propionibacterium acnes for use as vaccine candidates to prevent infection by the pig pathogen Actinobacillus pleuropneumoniae.
Li L; Sun C; Yang F; Yang S; Feng X; Gu J; Han W; Langford PR; Lei L
Vaccine; 2013 Oct; 31(45):5269-75. PubMed ID: 24051157
[TBL] [Abstract][Full Text] [Related]
16. A bivalent fusion vaccine composed of recombinant Apx proteins shows strong protection against Actinobacillus pleuroneumoniae serovar 1 and 2 in a mouse model.
Park BS; Lee N
Pathog Dis; 2019 Mar; 77(2):. PubMed ID: 30939190
[TBL] [Abstract][Full Text] [Related]
17. Recombinant ApxIV protein enhances protective efficacy against Actinobacillus pleuropneumoniae in mice and pigs.
Wu HC; Yeh PH; Hsueh KJ; Yang WJ; Chu CY
J Appl Microbiol; 2018 Jun; 124(6):1366-1376. PubMed ID: 29431246
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and protective efficacy of ApxIA and ApxIIA DNA vaccine against Actinobacillus pleuropneumoniae lethal challenge in murine model.
Chiang CH; Huang WF; Huang LP; Lin SF; Yang WJ
Vaccine; 2009 Jul; 27(34):4565-70. PubMed ID: 19520199
[TBL] [Abstract][Full Text] [Related]
19. Induction of protective immune responses against challenge of Actinobacillus pleuropneumoniae by oral administration with Saccharomyces cerevisiae expressing Apx toxins in pigs.
Shin MK; Kang ML; Jung MH; Cha SB; Lee WJ; Kim JM; Kim DH; Yoo HS
Vet Immunol Immunopathol; 2013 Jan; 151(1-2):132-9. PubMed ID: 23206402
[TBL] [Abstract][Full Text] [Related]
20. [Cloning and expression of hemolytic-toxin from Actinobacillus pleuropneumoniae and the immunoprotection in mice].
Du A; Diao Y; Zhang W; Zhang R; Zang D; Liu F
Wei Sheng Wu Xue Bao; 2008 Mar; 48(3):342-8. PubMed ID: 18479061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]